PitchSend

Popular
Blog
Companies
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Healthy Growth across all verticals in FY'22 slide image

Healthy Growth across all verticals in FY'22

Healthy growth in Revenue & Profit REVENUE FY'22 Consolidated FY'21 FY'22 growth (Rs Cr) (Rs Cr) Total revenue 116.12 183.84 58% EBITDA 25.24 43.46 72% EBITDA % 21.7% 23.6% 190 bps PAT 11.7 24.8 112% PAT % 10.10% 13.51% 341 bps BETA Brugs DRUGS LTD. 1
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube